找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Biomarkers in Liver Disease; Vinood B. Patel,Victor R. Preedy Reference work 2017 Springer Science+Business Media Dordrecht 2017 Applicati

[复制链接]
楼主: False-Negative
发表于 2025-3-25 04:33:19 | 显示全部楼层
Interaction of Sialyltransferases, Sialidases, and Sialic Acids in Liver Diseases and Applications teen evaluated in liver diseases, and significant alterations have been found. Detailed understanding of the role of sialic acid, sialidases, and sialyltransferases and their interactions in liver diseases may significantly contribute to open new exciting frontiers of basic and therapeutic exploratio
发表于 2025-3-25 10:08:09 | 显示全部楼层
AST-to-Platelet Ratio Index (APRI) as Marker in Liver Diseaseant fibrosis. It showed promising results for predicting the presence of fibrosis in pediatric patients with NAFLD. Transient elastography, a noninvasive and objective but expensive method, showed higher performance in diagnosing significant fibrosis than APRI.
发表于 2025-3-25 13:08:00 | 显示全部楼层
Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Diseasecant fibrosis exceeding standard diagnostic scores such as APRI and FIB-4. Lower levels are found in nonalcoholic fatty liver disease (NAFLD), but sCD163 adds diagnostic information on the important identification of patients with advanced disease..The emerging picture from the increasing number of
发表于 2025-3-25 16:06:59 | 显示全部楼层
CD133 and EpCAM as Biomarkers in Liver Diseasesdifferentiation, migration, and cell survival. Wnt/β-catenin signaling pathway is the major pathway involved in EpCAM-positive hepatic cancers. CD133 and EpCAM have several significant clinical implications in diagnosis, prognosis, and therapy of human liver cancers. Recently defined histological ty
发表于 2025-3-25 22:07:21 | 显示全部楼层
Graft-Derived Cell-Free DNA as a Biomarker in Liver Transplantationr more effective treatment intervention. It is especially helpful to guide changes in immunosuppression and to monitor immunosuppression minimization. This new approach may contribute to achieve more effective, less toxic personalized immunosuppression.
发表于 2025-3-26 03:37:14 | 显示全部楼层
https://doi.org/10.1007/978-94-007-7675-3Application to prognosis; Biomarkers in disease; Cancer Research; Discovery of biomarkers; High throughp
发表于 2025-3-26 06:52:39 | 显示全部楼层
发表于 2025-3-26 11:33:23 | 显示全部楼层
发表于 2025-3-26 13:14:09 | 显示全部楼层
Biomarkers in Disease: Methods, Discoveries and Applicationshttp://image.papertrans.cn/b/image/187816.jpg
发表于 2025-3-26 18:11:27 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-30 02:59
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表